Aptamer unveils promising fibrosis treatment data
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aptamer Group PLC (APTA)
Aptamer Group PLC stock price live, this page displays LON APTA stock exchange data. View the APTA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aptamer Group PLC real time stock price chart below.
What Is the Aptamer Group PLC Stock Price Today?
The Aptamer Group PLC stock price today is 1.00.
What Is the Stock Symbol for Aptamer Group PLC?
The stock symbol for Aptamer Group PLC is ""APTA.""
What Stock Exchange Does Aptamer Group PLC Trade On?
Aptamer Group PLC is listed and trades on the London stock exchange.
Is Aptamer Group PLC a Good Stock to Buy?
Determining whether Aptamer Group PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APTA quote. (ISIN: GB00BNRRP542)
What Is the Aptamer Group PLC Stock Price Today?
The Aptamer Group PLC stock price today is 1.00.
What Is the Stock Symbol for Aptamer Group PLC?
The stock symbol for Aptamer Group PLC is ""APTA.""
What Stock Exchange Does Aptamer Group PLC Trade On?
Aptamer Group PLC is listed and trades on the London stock exchange.
Is Aptamer Group PLC a Good Stock to Buy?
Determining whether Aptamer Group PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APTA quote. (ISIN: GB00BNRRP542)
London
Currency in GBP
1.00
-0.05(-4.76%)
Closed·
Fair Value
An estimate of a Aptamer's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.95
1.10
52 wk Range
0.20
1.57
APTA Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
APTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Aptamer's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.951.10
52 wk Range
0.201.57
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
APTA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Aptamer's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Aptamer Group PLC Company Profile
Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies. It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company has strategic partnership with Unilever for the development of Optimer for use in deodorant, Neuro-Bio to develop reagents for Alzheimer’s disease test, and other pharma partner and AztraZeneca for drug delivery vehicle for fibrotic liver. Aptamer Group PLC has a development agreement with Invizius for the development of therapeutic. The company was founded in 2008 and is headquartered in York, the United Kingdom.
Compare APTA to Peers and Sector
Metrics to compare | APTA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPTAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.9x | −3.4x | −0.6x | |
PEG Ratio | −0.13 | −0.05 | 0.00 | |
Price/Book | 10.5x | 2.9x | 2.6x | |
Price / LTM Sales | 22.2x | 12.8x | 3.3x | |
Upside (Analyst Target) | - | 96.6% | 38.1% | |
Fair Value Upside | Unlock | 4.2% | 4.4% | Unlock |
Earnings
Latest Release
Mar 11, 2025
EPS / Forecast
-- / --
Revenue / Forecast
653.00K / --
People Also Watch
FAQ
What Stock Exchange Does Aptamer Trade On?
Aptamer is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Aptamer?
The stock symbol for Aptamer is "APTA."
What Is the Aptamer Market Cap?
As of today, Aptamer market cap is 27.10M.
What Is Aptamer's Earnings Per Share (TTM)?
The Aptamer EPS (TTM) is -0.00.
When Is the Next Aptamer Earnings Date?
Aptamer will release its next earnings report on 20 Oct 2025.
From a Technical Analysis Perspective, Is APTA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Aptamer Stock Split?
Aptamer has split 0 times.
How Many Employees Does Aptamer Have?
Aptamer has 28 employees.
What is the current trading status of Aptamer (APTA)?
As of 07 Sept 2025, Aptamer (APTA) is trading at a price of 1.00, with a previous close of 1.05. The stock has fluctuated within a day range of 0.95 to 1.10, while its 52-week range spans from 0.20 to 1.57.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.